Item 9 Labs

Growth Stage

The First U.S. Vertically Integrated Cannabis Franchise.

Analytics

Raised to Date: Raised: $47,824

Aggregate Commitments $

Platform

Dalmore Group

Start Date

02/25/2022

Close Date

02/25/2023

Min. Goal

$1,500

Max. Goal

$42,000,000

Min. Investment

$1,500

Security Type

Equity - Common

Funding Type

RegA+

Series

Series A

Price Per Share

$1.40

Pre-Money Valuation

$133,057,658

Rolling Commitments $

Status

Active

Reporting Date

05/21/2022

Days Remaining

280

% of Min. Goal

3,188%

% of Max. Goal

0%

Likelihood of Max
unlikely
Avg. Daily Raise

$563

Momentum
cold.svg
Log in or create a free account today to gain access to KingsCrowd analytics.
Location

Phoenix, Arizona

Industry

Alcohol, Tobacco, & Recreational Drugs

Tech Sector

Non-Tech

Distribution Model

B2B/B2C

Margin

Low

Capital Intensity

High

Business Type

Growth

Item 9 Labs is raising funds on Dalmore Group through Reg A+ crowdfunding. The company makes and sells cannabis-derived products in licensed medical and adult-use dispensaries. The business also sells cannabis dispensary franchises under its franchise brand, Unity Rd. Item 9 Labs has won cannabis licenses in 17 states, over 45 cannabis and franchise industry awards, and more than 300 franchise awards in 15 countries. Andrew Bowden founded Item 9 Labs in 2010. The current crowdfunding campaign has no minimum target and a maximum target of $42,000,000. The campaign proceeds will be used for the acquisition of retail dispensary businesses, cultivation and production businesses, working capital, and general corporate purposes.

Balance Sheet

Cash and Cash Equivalents

$1,454,460

Investment Securities

$0

Total Investments

$0

Accounts and Notes Receivable

$1,448,280

Loans

$0

Property, Plant and Equipment (PP&E)

$10,877,848

Property and Equipment

$0

Total Assets

$116,809,133

Accounts Payable & Accrued Liabilities

$3,759,818

Policy Liabilities and Accruals

$0

Deposits

$0

Long Term Debt

$20,770,795

Total Liabilities

$30,707,690

Total Stockholders' Equity

$86,101,443

Total Liabilities and Equity

$116,809,133

Statement of Comprehensive Income Information

Total Revenues

$21,937,227

Total Interest Income

$0

Costs & Expenses Applicable to Rev

$13,324,284

Total Interest Expenses

$0

Depreciation and Amortization

$1,085,847

Net Income

$-10,905,772

Earnings Per Share - Basic

$0

Earnings Per Share - Diluted

$0

Auditor: BF Borgers CPA PC
Financials as of: 02/25/2022
Log in or create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Starter

$8.33 /month
billed annually
Free portfolio tracking. Limited reports and filters.
Plan Includes:
Everything in Free, plus
Advanced company search ( limited filters)
Founder profiles and exclusive webinars
2 Analyst Reports per month
Get Starter Annual

Pro

$25 /month
billed annually
Unlimited analyst reports and market analytics.
Plan Includes:
Everything in Starter, plus
Full access to all Analyst Reports
Filter on Analyst Reports (e.g. Top Deal, Deal to Watch, etc.)
Market Analytics
Get Pro Annual

Merlin

$41.67 /month
billed annually
Full site access including KingsCrowd ratings.
Plan Includes:
Everything in Pro, plus
Search and filter companies by KingsCrowd ratings
Company specific KingsCrowd rating and risk assessment
Get Merlin Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Analyst Report Analyst Report Methodology Article

Create your first portfolio

Create your very own investment portfolio on KingsCrowd.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Item 9 Labs on Dalmore Group 2022
$
Platform: Dalmore Group
Security Type: Equity - Common
Valuation: $133,057,658

Follow company

Follow Item 9 Labs on Dalmore Group 2022
View on Dalmore Group
Bullish / Bearish
You're Bullish on Item 9 Labs on Dalmore Group 2022

Thank you for your vote on Item 9 Labs on Dalmore Group 2022

Bullish / Bearish
You're Bearish on Item 9 Labs on Dalmore Group 2022

Thank you for your vote on Item 9 Labs on Dalmore Group 2022